TrialBlood advances2025

Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials.

María-Victoria Mateos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.